$EXEL
Exelixis Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$58.30
▼-0.05%-$0.030
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateExelixis Inc
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is EXEL up today? It is at $58.30 (+0.00%), and our scanner flagged it 88 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment EXEL spikes, and full due diligence on EXEL — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $EXEL 88 times in the last 30 days. Create a free account to track $EXEL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on EXEL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for EXEL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Beckerle Mary C Director | Sold (automatic/other) | -10K | sold 38% | 16K | $527K at $53.66 | Aug 10, 26 |
Eckhardt Sue Gail Director | Sold (automatic/other) | -10K | sold 38% | 16K | $492K at $50.14 | Jun 1, 26 |
Wyszomierski Jack L Director | Sold (automatic/other) | -4K | sold 1.4% | 284K | $198K at $50.55 | Jun 1, 26 |
Poste George Director | Acquired (grant/award) | +8K | added 7.0% | 127K | n/a | May 27, 26 |
Wyszomierski Jack L Director | Acquired (grant/award) | +8K | added 3.0% | 288K | n/a | May 27, 26 |
Oliver Bob Director | Acquired (grant/award) | +8K | added 40% | 29K | n/a | May 27, 26 |
Freire Maria C Director | Acquired (grant/award) | +8K | added 8.3% | 109K | n/a | May 27, 26 |
Beckerle Mary C Director | Acquired (grant/award) | +8K | added 48% | 26K | n/a | May 27, 26 |
Smith Julie Director | Acquired (grant/award) | +8K | added 41% | 29K | n/a | May 27, 26 |
Heyman Tomas J. Director | Acquired (grant/award) | +8K | added 20% | 51K | n/a | May 27, 26 |
Eckhardt Sue Gail Director | Acquired (grant/award) | +8K | added 48% | 26K | n/a | May 27, 26 |
Papadopoulos Stelios Director | Acquired (grant/award) | +8K | added 0.7% | 1.20M | n/a | May 27, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on EXEL from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for EXEL today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
EXEL last traded at $58.30, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Exelixis Inc (EXEL) is next expected to report earnings on Tuesday, November 3, 2026, about 27 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The EXEL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged EXEL 88 times in the last 30 days.
EXEL (Exelixis Inc) trades on XNAS, with a market cap of about $14.45B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge EXEL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$EXEL discussion
Sign in to ask a question or join the discussion.